MRD negativity (10–5) rates
| . | KdD % (95% CI) n = 312 . | Kd % (95% CI) n = 154 . | ORs KdD/Kd (95% CI) . |
|---|---|---|---|
| MRD– rate at 12 mo | n = 57 18.3 (14.1-23.0) | n = 8 5.2 (2.3-10.0) | 4.403 (2.007-9.656) |
| MRD– CR rate at 12 mo | n = 40 12.8 (9.3-17.0) | n = 3 1.9 (0.4-5.6) | 7.819 (2.364-25.858) |
| MRD− rate at any time | n = 87 27.9 (23.0-33.2) | n = 14 9.1 (5.1-14.8) | 4.222 (2.277-7.829) |
| MRD− CR rate at any time | n = 68 21.8 (17.3-26.8) | n = 12 7.8 (4.1-13.2) | 3.551 (1.833-6.877) |
| . | KdD % (95% CI) n = 312 . | Kd % (95% CI) n = 154 . | ORs KdD/Kd (95% CI) . |
|---|---|---|---|
| MRD– rate at 12 mo | n = 57 18.3 (14.1-23.0) | n = 8 5.2 (2.3-10.0) | 4.403 (2.007-9.656) |
| MRD– CR rate at 12 mo | n = 40 12.8 (9.3-17.0) | n = 3 1.9 (0.4-5.6) | 7.819 (2.364-25.858) |
| MRD− rate at any time | n = 87 27.9 (23.0-33.2) | n = 14 9.1 (5.1-14.8) | 4.222 (2.277-7.829) |
| MRD− CR rate at any time | n = 68 21.8 (17.3-26.8) | n = 12 7.8 (4.1-13.2) | 3.551 (1.833-6.877) |
OR, odds ratio.